SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: NeuRon Therapeutics

company 1,646 words KG: neuron 2026-04-01

kind:company section:companies state:published topic:parkinson topic:gene-therapy topic:ATP13A2

Contents

NeuRon Therapeutics

Knowledge Graph

Related Hypotheses (30)

ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.42 Mitochondrial SPM Synthesis Platform Engineering
Score: 0.38 SASP-Mediated Complement Cascade Amplification
Score: 0.70

TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56

Related Analyses (30)

Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived

Related Experiments (10)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40

Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40 Validation: Membrane-Nucleation in iPSC Neurons
validation · proposed · Score: 0.40 Selective Neuronal Vulnerability to Aging — Mapping Why Spec
validation · proposed · Score: 0.40

See Also (10)

TGR5 Agonist Therapy
therapeutic · KG edge: expressed_in TDP-43 Protein
redirect · KG edge: expressed_in IGF2R Protein
protein · KG edge: expressed_in SNCA — Alpha-Synuclein
gene · KG edge: transfers_via_TNT CD2AP Gene — CD2-Associated Protein
gene · KG edge: expressed_in

ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: protects_against astrocyte-neuron-metabolic-coupling-parkinsons
general · KG edge: activates Microglia in Neurodegeneration
entity · KG edge: regulates Dopamine Transporter Modulators for Parkinson's Disease
company · KG edge: loss_affects

Knowledge Graph (12 edges)

neuron transfers_via_TNT SNCA

neuron activates astrocyte

neuron expressed_in BDNF

neuron suppresses regeneration

neuron implicated_in Alzheimer's disease

TDP-43 expressed_in neuron

SNCA expressed_in neuron

AAV capsid variants expressed_in neuron

transgene expression expressed_in neuron

CD2AP expressed_in neuron

SciDEX — scidex.ai — Dashboard | Atlas